![]() |
Volumn 15, Issue 3, 2002, Pages 233-240
|
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme
|
Author keywords
Angiogenesis inhibition; Contrast enhanced; Glioblastoma multiforme; Microvascular permeability; MRI; Tumor treatment monitoring
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
GADOLINIUM PENTETATE;
GADOLINIUM PENTETATE MEGLUMINE;
MONOCLONAL ANTIBODY A4.6.1;
UNCLASSIFIED DRUG;
VASCULOTROPIN ANTIBODY;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BLOOD VESSEL PERMEABILITY;
CANCER GROWTH;
CANCER INHIBITION;
CONTRAST ENHANCEMENT;
CONTROLLED STUDY;
GLIOBLASTOMA;
HUMAN;
HUMAN CELL;
MICROVASCULATURE;
NON INVASIVE MEASUREMENT;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT MONITORING;
PRIORITY JOURNAL;
RAT;
TUMOR VOLUME;
TUMOR XENOGRAFT;
VASCULAR ENDOTHELIUM;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BRAIN NEOPLASMS;
CAPILLARY PERMEABILITY;
CONTRAST MEDIA;
ENDOTHELIAL GROWTH FACTORS;
GLIOBLASTOMA;
MAGNETIC RESONANCE IMAGING;
RATS;
RATS, NUDE;
TUMOR CELLS, CULTURED;
TUMOR MARKERS, BIOLOGICAL;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0036189478
PISSN: 10531807
EISSN: None
Source Type: Journal
DOI: 10.1002/jmri.10072 Document Type: Article |
Times cited : (150)
|
References (31)
|